Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Chronic Obstructive Pulmonary Disease-V: Management01:29

Chronic Obstructive Pulmonary Disease-V: Management

Managing Chronic Obstructive Pulmonary Disease (COPD) involves a multifaceted approach to reduce symptoms, prevent exacerbations, improve overall health status, and slow disease progression. Key strategies include lifestyle modifications, pharmacotherapy, supportive therapies, and, in some cases, surgery. Here is an overview of the primary COPD management strategies:
Smoking Cessation
Chronic Obstructive Pulmonary Disease01:24

Chronic Obstructive Pulmonary Disease

COPD is defined as a heterogeneous lung condition marked by persistent respiratory symptoms such as dyspnea, cough, and sputum production, caused by abnormalities in the airways that cause airflow obstruction.
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
Chronic Obstructive Pulmonary Disease-I: Introduction01:20

Chronic Obstructive Pulmonary Disease-I: Introduction

Chronic Obstructive Pulmonary Disease (COPD) is a long-lasting respiratory condition requiring continuous attention and care. It is a progressive lung disease that leads to breathing challenges due to airflow obstruction. It manifests as persistent respiratory symptoms and restricted airflow resulting from abnormalities in the airways and alveoli, usually due to long-term exposure to harmful particles or gases. COPD mainly consists of two primary conditions: emphysema and chronic bronchitis.
Chronic Obstructive Pulmonary Disease I: Introduction01:23

Chronic Obstructive Pulmonary Disease I: Introduction

Chronic obstructive pulmonary disease is a common, preventable, and treatable respiratory disorder characterized by persistent symptoms and progressive airflow limitation. This limitation results from a combination of small-airway disease (obstructive bronchiolitis) and parenchymal destruction (emphysema), both driven by chronic inflammation from exposure to harmful particles or gases.The disease includes two main pathological entities: emphysema, marked by destruction of alveolar walls and...
Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features01:24

Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features

Chronic bronchitis is a key phenotype of chronic obstructive pulmonary disease (COPD), characterized by airway-centered inflammation and mucus overproduction. It develops from long-term exposure to harmful particles or gases, most commonly cigarette smoke, which triggers a persistent inflammatory response.Cellular and Structural ChangesInflammation initially affects the large bronchi and later the smaller airways, with infiltration by immune cells, including neutrophils, macrophages, and...
Chronic Obstructive Pulmonary Disease-III: Symptoms and Complications.01:25

Chronic Obstructive Pulmonary Disease-III: Symptoms and Complications.

Understanding the variety of primary symptoms and systemic complications that characterize chronic obstructive pulmonary disease (COPD) is crucial for healthcare professionals.
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD:

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Beta-blockers are under-prescribed in patients with chronic obstructive pulmonary disease and co-morbid cardiac disease.

Internal medicine journal·2016
Same author

Multi-site placebo-controlled randomised clinical trial to assess protection following oral immunisation with inactivated non-typeable Haemophilus influenzae in chronic obstructive pulmonary disease.

Internal medicine journal·2016
Same author

Characterization of M1/M2 Tumour-Associated Macrophages (TAMs) and Th1/Th2 Cytokine Profiles in Patients with NSCLC.

Cancer microenvironment : official journal of the International Cancer Microenvironment Society·2015
Same author

Minimal important difference in field walking tests in non-cystic fibrosis bronchiectasis following exercise training.

Respiratory medicine·2014
Same author

Suboptimal management of unfractionated heparin compared with low-molecular-weight heparin in the management of pulmonary embolism.

Internal medicine journal·2014
Same author

Late presentation of familial Mediterranean fever associated with P369S/R408Q variant in the MEFV gene.

Internal medicine journal·2012

Related Experiment Video

Updated: May 9, 2026

Generation of a Chronic Obstructive Pulmonary Disease Model in Mice by Repeated Ozone Exposure
08:17

Generation of a Chronic Obstructive Pulmonary Disease Model in Mice by Repeated Ozone Exposure

Published on: August 25, 2017

Advances in chronic obstructive pulmonary disease.

C F McDonald1, Y Khor

  • 1Respiratory and Sleep Medicine, Austin Hospital, Melbourne, Victoria, Australia. christine.mcdonald@austin.org.au

Internal Medicine Journal
|August 8, 2013
PubMed
Summary
This summary is machine-generated.

Chronic obstructive pulmonary disease (COPD) is a progressive lung condition. Management involves smoking cessation, medication, and addressing comorbidities to improve quality of life and potentially slow disease progression.

Keywords:
COPDchronicchronic obstructive pulmonary diseaselung diseaseupdate

More Related Videos

Auricular Acupuncture as a Traditional Chinese Medicine Therapy for Chronic Obstructive Pulmonary Disease Combined with Sleep Disorders
05:34

Auricular Acupuncture as a Traditional Chinese Medicine Therapy for Chronic Obstructive Pulmonary Disease Combined with Sleep Disorders

Published on: August 18, 2023

Acupoint Application Combined with Ear Plaster Therapy for Treating Sleep Disorders with Acute Exacerbation of Chronic Obstructive Pulmonary Disease
04:53

Acupoint Application Combined with Ear Plaster Therapy for Treating Sleep Disorders with Acute Exacerbation of Chronic Obstructive Pulmonary Disease

Published on: October 18, 2024

Related Experiment Videos

Last Updated: May 9, 2026

Generation of a Chronic Obstructive Pulmonary Disease Model in Mice by Repeated Ozone Exposure
08:17

Generation of a Chronic Obstructive Pulmonary Disease Model in Mice by Repeated Ozone Exposure

Published on: August 25, 2017

Auricular Acupuncture as a Traditional Chinese Medicine Therapy for Chronic Obstructive Pulmonary Disease Combined with Sleep Disorders
05:34

Auricular Acupuncture as a Traditional Chinese Medicine Therapy for Chronic Obstructive Pulmonary Disease Combined with Sleep Disorders

Published on: August 18, 2023

Acupoint Application Combined with Ear Plaster Therapy for Treating Sleep Disorders with Acute Exacerbation of Chronic Obstructive Pulmonary Disease
04:53

Acupoint Application Combined with Ear Plaster Therapy for Treating Sleep Disorders with Acute Exacerbation of Chronic Obstructive Pulmonary Disease

Published on: October 18, 2024

Area of Science:

  • Pulmonology
  • Internal Medicine

Background:

  • Chronic obstructive pulmonary disease (COPD) is defined by progressive airflow limitation and is linked to identifiable risk factors.
  • Inflammation is a key pathological feature in COPD pathogenesis, leading to pulmonary and extrapulmonary manifestations like heart disease, stroke, and diabetes.
  • Anxiety and depression are frequently observed comorbidities in individuals with COPD.

Purpose of the Study:

  • To provide a comprehensive overview of COPD diagnosis, management, and associated comorbidities.
  • To highlight the importance of pharmacologic and non-pharmacologic therapies in improving patient outcomes.
  • To emphasize the role of smoking cessation, physical activity, and pulmonary rehabilitation in COPD management.

Main Methods:

  • Diagnosis relies on spirometry as the gold standard.
  • Treatment strategies include pharmacologic therapies (primarily bronchodilators) and non-pharmacologic approaches.
  • Management also encompasses addressing comorbidities and providing ongoing patient support.

Main Results:

  • Pharmacologic and non-pharmacologic therapies can enhance symptoms, quality of life, and exercise capacity.
  • Effective management, including smoking cessation and pulmonary rehabilitation, can reduce exacerbations and potentially modify disease progression.
  • Active management of comorbidities is crucial for overall patient well-being.

Conclusions:

  • COPD requires a multifaceted management approach, including bronchodilators, smoking cessation, and pulmonary rehabilitation.
  • Addressing extrapulmonary manifestations and comorbidities is essential for comprehensive patient care.
  • Ongoing monitoring and advanced-care planning are recommended due to the chronic and progressive nature of COPD.